Pharmosa Biopharm Inc. (TPEX:6875)

Pharmosa Biopharm Revenue

Pharmosa Biopharm had revenue of 40.90M TWD in the quarter ending September 30, 2024, a decrease of -86.99%. This brings the company's revenue in the last twelve months to 50.52M, down -83.94% year-over-year. In the year 2023, Pharmosa Biopharm had annual revenue of 314.50M.

• Revenue (ttm): 50.52M
• Revenue Growth: -83.94%
• P/S Ratio: 148.58
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 7.85B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	314.50M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-